What question did this study set out to answer?

This research aims to evaluate and compare the efficacy of interleukin-6 and BacT/ALERT in diagnosing neonatal sepsis.

Enhancing neonatal sepsis detection: A comparative analysis of interleukin-6 and the BacT/ALERT blood culture system

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial compares interleukin-6 and BacT/ALERT for diagnosing neonatal sepsis, suggesting improved outcomes through combined methods.

This research aims to evaluate and compare the efficacy of interleukin-6 and BacT/ALERT in diagnosing neonatal sepsis.
Evaluated 120 neonates in a NICU suspected of sepsis, aged 0-28 days, meeting specific inclusion criteria.
Assessed IL-6 levels and bacterial growth using BacT/ALERT for diagnosis.
Analyzed sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for IL-6 and BacT/ALERT.
IL-6 was elevated in 45% of neonates, showing sensitivity of 100%, specificity of 86.84%, PPV of 81.48%, and NPV of 100%.
BacT/ALERT identified bacterial growth in 36.67% of samples, but results took longer than IL-6.
IL-6 provided results in three hours, significantly faster than the BacT/ALERT method.

Kumar et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial compares interleukin-6 and BacT/ALERT for diagnosing neonatal sepsis, suggesting improved outcomes through combined methods.